New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression
about
LncRNA2Function: a comprehensive resource for functional investigation of human lncRNAs based on RNA-seq dataBmcc1s, a novel brain-isoform of Bmcc1, affects cell morphology by regulating MAP6/STOP functions.Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining toolFunction of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score.Novel diagnostic biomarkers for prostate cancer.PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling.Identification of novel tissue-specific genes by analysis of microarray databases: a human and mouse model.BMCC1 is an AP-2 associated endosomal protein in prostate cancer cellsPRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis.Circadian changes in long noncoding RNAs in the pineal gland.Evaluation of a short RNA within Prostate Cancer Gene 3 in the predictive role for future cancer using non-malignant prostate biopsies.Regulators of gene expression as biomarkers for prostate cancerPathogenetic model for Tourette syndrome delineates overlap with related neurodevelopmental disorders including Autism.Evaluation of prostate cancer antigen 3 for detecting prostate cancer: a systematic review and meta-analysis.Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers.Markers for detection of prostate cancer.The prognostic role of PRUNE2 in leiomyosarcoma.Urine markers in monitoring for prostate cancer.KLRC3, a Natural Killer receptor gene, is a key factor involved in glioblastoma tumourigenesis and aggressivenessFunctional plasticity of the BNIP-2 and Cdc42GAP Homology (BCH) domain in cell signaling and cell dynamics.PCA3 and TMPRSS2-ERG: Promising Biomarkers in Prostate Cancer Diagnosis.Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.Somatic Mutation Analyses in Studies of the Clonal Evolution and Diagnostic Targets of Prostate Cancer.PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells.Assessing blood platelets as RNA biomarker source for prostate cancer.Mammalian diseases of phosphatidylinositol transfer proteins and their homologs.Cancer-related PRUNE2 protein is associated with nucleotides and is highly expressed in mature nerve tissues.From biomarkers to therapeutic targets-the promises and perils of long non-coding RNAs in cancer.Emerging biomarkers in the diagnosis of prostate cancer.The use of long non-coding RNAs as prognostic biomarkers and therapeutic targets in prostate cancer.
P2860
Q30898138-A821A78B-E29A-4017-AB74-ED92F088F8D1Q31055950-EB61E37A-6840-4607-A50C-C1069197422FQ33728046-54F45333-83E3-47BB-ADAF-4F059E6EC318Q34130249-637C8BB8-EBA9-4D36-B705-D848D655B1A2Q34231678-C4625A38-283E-4912-BDD5-7ABC5816E1BEQ34468270-090E1D63-8E9C-43A6-92C0-7D026B18AD00Q34760518-87D578D5-62C6-4DA9-BFB8-7BC8065013E0Q34989460-3066843F-E69F-421B-955D-E71AA4E51694Q35845897-865B80D2-A964-4D69-A749-4F1C85F7C6B9Q36049081-5188F80E-13F8-486B-BD7A-497BBB2D5A9DQ36170825-1CF92717-5161-4647-9C8C-7EA22A70AA47Q36336025-4631DED6-592C-4755-9BE5-87A384425FFFQ36439912-74D7CDB9-5986-40EA-A548-D58A70BCF5EDQ36589721-7586A221-42CD-48A2-A264-5D859772EAC1Q36886346-9D08682B-307E-4EB5-9F6F-1B43F97D2B63Q37273884-7D5BE8E9-9810-40FB-8270-1FB31BD1276FQ37328403-A323375C-7A9F-46B6-90E0-49F7921F7E16Q37409767-E51352F1-2F27-4FA2-ACE3-E3199915CF2BQ37571461-9BFB11E7-29E8-44E8-AA43-D58C1040E738Q37604367-5D00AF1D-9C73-4DCC-BE17-818F5978A20CQ38019705-2A0724F4-8125-41F5-9596-004BD0E6CB1BQ38166577-A821A407-264D-480A-A354-8EAA9B66476AQ38255363-2E27C1A5-3851-451C-B790-95D89723A0F6Q38703676-5CAE32EB-9ADE-4667-B6E1-80A1AAF03B52Q38787568-BFE005C3-2CAA-42BD-8B95-005BE220CBEBQ39816671-51CC4D38-8106-4818-8199-71B9385F1C37Q42736093-C853B35E-473E-49DD-9AA4-4F621C42A2C6Q46231000-D1D2C262-CCAD-4602-B146-DB99B1A71CE0Q47287055-A7F52E84-71DF-4185-81E1-2E385F655B76Q54964875-557AB2AD-0EC4-4927-8362-F49923C65B7CQ55356724-B368F009-6DD4-4F23-A6E5-D9215707A182
P2860
New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
New genomic structure for pros ...... ncer detection and progression
@ast
New genomic structure for pros ...... ncer detection and progression
@en
New genomic structure for pros ...... ncer detection and progression
@en-gb
New genomic structure for pros ...... ncer detection and progression
@nl
type
label
New genomic structure for pros ...... ncer detection and progression
@ast
New genomic structure for pros ...... ncer detection and progression
@en
New genomic structure for pros ...... ncer detection and progression
@en-gb
New genomic structure for pros ...... ncer detection and progression
@nl
altLabel
New Genomic Structure for Pros ...... ncer Detection and Progression
@en
prefLabel
New genomic structure for pros ...... ncer detection and progression
@ast
New genomic structure for pros ...... ncer detection and progression
@en
New genomic structure for pros ...... ncer detection and progression
@en-gb
New genomic structure for pros ...... ncer detection and progression
@nl
P2093
P2860
P3181
P1433
P1476
New genomic structure for pros ...... ncer detection and progression
@en
P2093
An-Yuan Guo
Kathrein Roper
Linda Teng
Martin F Lavin
Raymond A Clarke
Robert A Gardiner
Zhi-Ming Fang
Zhongming Zhao
P2860
P3181
P356
10.1371/JOURNAL.PONE.0004995
P407
P577
2009-01-01T00:00:00Z